MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 91 filers reported holding MYOVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $105,602 | +50.9% | 3,917 | 0.0% | 0.00% | – |
| Q3 2022 | $70,000 | +42.9% | 3,917 | 0.0% | 0.00% | – |
| Q2 2022 | $49,000 | -5.8% | 3,917 | 0.0% | 0.00% | – |
| Q1 2022 | $52,000 | -14.8% | 3,917 | 0.0% | 0.00% | – |
| Q4 2021 | $61,000 | -30.7% | 3,917 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | -1.1% | 3,917 | 0.0% | 0.00% | – |
| Q2 2021 | $89,000 | +9.9% | 3,917 | 0.0% | 0.00% | – |
| Q1 2021 | $81,000 | -46.7% | 3,917 | -29.0% | 0.00% | -100.0% |
| Q4 2020 | $152,000 | +94.9% | 5,518 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $78,000 | -31.6% | 5,518 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $114,000 | +171.4% | 5,518 | 0.0% | 0.00% | – |
| Q1 2020 | $42,000 | -51.2% | 5,518 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $86,000 | +616.7% | 5,518 | +133.4% | 0.00% | – |
| Q3 2019 | $12,000 | – | 2,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 65,000 | $808,000 | 1.13% |
| Bellevue Group AG | 5,919,639 | $73,581,000 | 1.04% |
| Rhenman & Partners Asset Management AB | 310,000 | $3,853,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 279,335 | $3,472,000 | 0.22% |
| TORRAY INVESTMENT PARTNERS LLC | 81,621 | $1,015,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 302,120 | $3,755,000 | 0.14% |
| Virtus ETF Advisers LLC | 22,356 | $278,000 | 0.10% |
| Tarbox Family Office, Inc. | 27,500 | $342,000 | 0.08% |
| BOURGEON CAPITAL MANAGEMENT LLC | 15,200 | $189,000 | 0.05% |
| JANUS HENDERSON GROUP PLC | 5,449,107 | $67,735,000 | 0.05% |